Delivery Order SPE2DB20D3303-SPE2DB26FY2J4
Award Date 11/6/25
Potential Completion Date 11/7/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,184.11 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. This non-competitive delivery order, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a firm fixed price transaction under DLA's pharmaceutical supply chain. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,464.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The award was issued on June 18, 2025, with an ultimate completion date of June 20, 2025, and was performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order was competitively awarded without set-aside restrictions, reflecting the contractor's established capability to meet federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $6,549.99 to AmerisourceBergen Drug Corp on September 8, 2025, for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. The contract is a firm fixed price delivery order with an ultimate completion date of September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition without a set-aside designation, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency awarded a delivery order valued at $9,190.25 to AmerisourceBergen Drug Corp on September 4, 2025, for OmniPod 5 Dexcom G7 insulin delivery pods (Generation 5), with a completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical device supplier to the federal government. The delivery will be fulfilled from the vendor's corporate office in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $18,650.04 for OmniPod 5 Dexcom G7 Gen 5 insulin infusion pods on September 25, 2025, with completion scheduled for September 26, 2025. This firm fixed-price delivery order was not set-aside and represents a competitive award under the company's existing contract vehicle with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $11,417.69 firm fixed price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 pods (Generation 5, 5-count). The contract, awarded on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a non-competitive, competitively awarded delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $21,396.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods on September 16, 2025, with completion due September 17, 2025. This non-set-aside competitive award will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical device supplier to...
- The Defense Logistics Agency awarded a $2,395.34 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The contract, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed price procurement with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this medical device delivery, which supports the federal government's...
- The Defense Logistics Agency awarded a $55,224.29 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 pods on September 15, 2025, with an ultimate completion date of September 16, 2025. The order, which represents a non-competitive delivery order, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $12,226.93 delivery order (contract 4569778423) to AmerisourceBergen Drug Corp on October 20, 2025, for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. This is a competitively awarded, firm fixed-price contract with no set-aside designation, and performance will be completed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is expected to conclude by October 21, 2025. This award represents a child delivery...